KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Assets Average: 2019-2025

Historic Assets Average for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $12.1 billion.

  • Moderna's Assets Average fell 23.31% to $12.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 billion, marking a year-over-year decrease of 23.31%. This contributed to the annual value of $16.3 billion for FY2024, which is 26.46% down from last year.
  • Moderna's Assets Average amounted to $12.1 billion in Q3 2025, which was down 2.30% from $12.4 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Assets Average ranged from a high of $26.8 billion in Q2 2022 and a low of $10.0 billion during Q1 2021.
  • Over the past 3 years, Moderna's median Assets Average value was $16.2 billion (recorded in 2024), while the average stood at $17.3 billion.
  • In the last 5 years, Moderna's Assets Average skyrocketed by 447.75% in 2021 and then dropped by 29.67% in 2024.
  • Over the past 5 years, Moderna's Assets Average (Quarterly) stood at $22.8 billion in 2021, then climbed by 13.87% to $26.0 billion in 2022, then declined by 27.04% to $18.9 billion in 2023, then dropped by 20.94% to $15.0 billion in 2024, then fell by 23.31% to $12.1 billion in 2025.
  • Its Assets Average was $12.1 billion in Q3 2025, compared to $12.4 billion in Q2 2025 and $13.4 billion in Q1 2025.